A randomized, double-blind, placebo-controlled trial of citicoline for bipolar and unipolar depression and methamphetamine dependence

Journal of Affective Disorders

Volumn 143, Issue 1-3, 2012, Pages 257-260

  Sherwood Brown, E ^a   Gabrielson, Barry ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Bipolar disorder; Citicoline; Cognition; Depression; Memory; Methamphetamine

Indexed keywords

CITICOLINE; METHAMPHETAMINE; PLACEBO;

ADULT; ARTICLE; BIPOLAR DEPRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HOPKINS AUDITORY VERBAL LEARNING TEST; HUMAN; INVENTORY OF DEPRESSIVE SYMPTOMATOLOGY CLINICIAN VERSION; MAJOR DEPRESSION; MALE; METHAMPHETAMINE DEPENDENCE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

ADULT; AGED; AMPHETAMINE-RELATED DISORDERS; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; CYTIDINE DIPHOSPHATE CHOLINE; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DUAL (PSYCHIATRY); DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; YOUNG ADULT;

EID: 84869489599     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2012.05.006     Document Type: Article

References (28)

1. R.M. Adibhatla, and J.F. Hatcher Cytidine 5-diphosphocholine (CDP-choline) in stroke and other CNS disorders Neurochemical Research 30 2005 15 23
2. J. Brandt The Hopkins verbal learning test: development of a new memory test with six equivalent norms The Clinical Neuropsychologist 5 1991 125 142
3. E.S. Brown, A.R. Gorman, and L.S. Hynan A randomized, placebo-controlled trial of citicoline add-on therapy in outpatients with bipolar disorder and cocaine dependence Journal of Clinical Psychopharmacology 27 2007 498 502
4. W.A. Carlezon, A.M. Pliakas, A.M. Parow, M.J. Detke, B.M. Cohen, and P.F. Renshaw Antidepressant-like effects of cytidine in the forced swim test in rats Biological Psychiatry 51 2002 882 889
5. W.M. Clark, B.J. Williams, K.A. Selzer, R.M. Zweifler, L.A. Sabounjian, and R.E. Gammans A randomized efficacy trial of citicoline in patients with acute ischemic stroke Stroke 30 1999 2592 2597
6. C.E. Dixon, X. Ma, and D.W. Marion Effects of CDP-choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetylcholine release Journal of Neurotrauma 14 1997 161 169
7. A.M. Elkashef, R.A. Rawson, A.L. Anderson, S.H. Li, T. Holmes, E.V. Smith, N. Chiang, R. Kahn, F. Vocci, W. Ling, V.J. Pearce, M. McCann, J. Campbell, C. Gorodetzky, W. Haning, B. Carlton, J. Mawhinney, and D. Weis Bupropion for the treatment of methamphetamine dependence Neuropsychopharmacology 33 2008 1162 1170
8. Fioravanti, M., Yanagi, M., 2005. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database of Systematic Reviews, CD000269.
9. M. First, R. Spitzer, M. Gibbon, and W. JBW Structured Clinical Interview for DSM-IV Axis I Disorders. Biometrics Research Department, New York State Psychiatric Institute, Department of Psychiatry 1995 Columbia University New York
10. S. Glasner-Edwards, L.J. Mooney, P. Marinelli-Casey, M. Hillhouse, A. Ang, and R.A. Rawson Psychopathology in methamphetamine-dependent adults 3 years after treatment Drug and Alcohol Review 29 2010 12 20
11. N. Jayaram-Lindstrom, A. Hammarberg, O. Beck, and J. Franck Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial The American Journal of Psychiatry 165 2008 1442 1448
12. N. Jayaram-Lindstrom, M. Konstenius, S. Eksborg, O. Beck, A. Hammarberg, and J. Franck Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence Neuropsychopharmacology 33 2008 1856 1863
13. B.A. Johnson, N. Ait-Daoud, A.M. Elkashef, E.V. Smith, R. Kahn, F. Vocci, S.H. Li, and D.A. Bloch A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence International Journal of Neuropsychopharmacology 11 2008 1 14
14. M. Longo, W. Wickes, M. Smout, S. Harrison, S. Cahill, and J.M. White Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence Addiction 105 2010 146 154
15. S.M. McClintock, M.M. Husain, T.L. Greer, and C.M. Cullum Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis Neuropsychology 24 2010 9 34
16. N. Nomamiukor, and E.S. Brown Attrition factors in clinical trials of comorbid bipolar and substance-related disorders Journal of Affective Disorders 112 2009 284 288
17. I.J. Osuji, and C.M. Cullum Cognition in bipolar disorder Psychiatric Clinics of North America 28 2005 427 441
18. V.D. Petkov, S.L. Stancheva, L. Tocuschieva, and V.V. Petkov Changes in brain biogenic monoamines induced by the nootropic drugs adafenoxate and meclofenoxate and by citicholine (experiments on rats) General Pharmacology 21 1990 71 75
19. R.A. Rawson, R. Gonzales, and P. Brethen Treatment of methamphetamine use disorders: an update Journal of Substance Abuse Treatment 23 2002 145 150
20. D.A. Regier, M.E. Farmer, D.S. Rae, B.Z. Locke, S.J. Keith, L.L. Judd, and F.K. Goodwin Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study Journal of the American Medical Association 264 1990 2511 2518
21. P.F. Renshaw, S. Daniels, L.H. Lundahl, V. Rogers, and S.E. Lukas Short-term treatment with citicoline (CDP-choline) attenuates some measures of craving in cocaine-dependent subjects: a preliminary report Psychopharmacology (Berl) 142 1999 132 138
22. J.M. Roll, N.M. Petry, M.L. Stitzer, M.L. Brecht, J.M. Peirce, M.J. McCann, J. Blaine, M. MacDonald, J. DiMaria, L. Lucero, and S. Kellogg Contingency management for the treatment of methamphetamine use disorders American Journal of Psychiatry 163 2006 1993 1999
23. A.J. Rush, C.M. Gullion, M.R. Basco, R.B. Jarrett, and M.H. Trivedi The Inventory of Depressive Symptomatology (IDS): psychometric properties Psychological Medicine 26 1996 477 486
24. F. Salvadorini, F. Galeone, M. Nicotera, M. Ombrato, and P. Saba Clinical evaluation of CDP-choline (Nicholin): efficacy As antidepressant treatment Current Therapeutic Research, Clinical and Experimental 18 1975 513 520
25. J. Shearer, S. Darke, C. Rodgers, T. Slade, I. van Beek, J. Lewis, D. Brady, R. McKetin, R.P. Mattick, and A. Wodak A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence Addiction 104 2009 224 233
26. M. Sofuoglu Cognitive enhancement as a pharmacotherapy target for stimulant addiction Addiction 105 2010 38 48
27. A.L. Stoll, G.S. Sachs, B.M. Cohen, B. Lafer, J.D. Christensen, and P.F. Renshaw Choline in the treatment of rapid-cycling bipolar disorder: clinical and neurochemical findings in lithium-treated patients Biological Psychiatry 40 1996 382 388
28. J. Tiihonen, K. Kuoppasalmi, J. Fohr, P. Tuomola, O. Kuikanmaki, H. Vorma, P. Sokero, J. Haukka, and E. Meririnne A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence American Journal of Psychiatry 164 2007 160 162